The DETECT study: Personalised treatment in advanced breast cancer based on circulating tumour cells

At the European Cancer Congress (ECC) 2015, Wolfgang Janni, MD, PhD University Hospital Ulm, Ulm, discusses the interim analysis of the DETECT study, which was designed to evaluate the prognostic and predictive value of HER2-status of circulating tumour cells in patients with metastatic breast cancer.

Year of Production:
Running Time:
Color/Sound:

2015
02:56
Color/Sound

Comments are closed.